How semaglutide affects your skin — and what to do about it

Step 1, Injection-site reactions: the most predictable skin response

For most people on weekly semaglutide injections, the first skin-related experience is at the injection site itself. Redness, mild swelling, bruising or a small itchy bump in the hours after injecting are all listed reactions. They are most common early in treatment, often settle within a day or two, and rarely require stopping the medicine.

Rotating sites consistently (abdomen, thigh or upper arm, never the same spot two weeks running) reduces the likelihood of local tissue reactions. Letting the pen reach room temperature before injecting, and pressing gently on the site (without rubbing) afterwards, are practical steps the full guide to injection-site discomfort with Wegovy covers in more detail.

A reaction that spreads, blisters, becomes very warm or does not resolve within a few days is a different matter and needs clinical review. Signs of a wider allergic response (facial swelling, difficulty breathing, a rash spreading away from the site) are urgent: call 999 or go to A&E. You can also report any suspected reaction through the MHRA's Yellow Card scheme, which tracks safety signals across medicines in the UK.

Step 2, Dryness, texture changes and what weight loss adds to the picture

Skin dryness appears in two ways on semaglutide. First, semaglutide slows gastric emptying and commonly causes nausea, reduced appetite and, in some people, episodes of vomiting or diarrhoea, particularly after a dose increase. If fluid intake drops or GI losses are significant, skin hydration follows. Drinking enough water through the day is genuinely useful here, not just a reflexive recommendation.

Second, meaningful weight loss (which is, of course, the point) changes the composition of the skin itself. Fat under the dermis provides structural support; as it reduces, some people notice their skin looking less firm, particularly around the abdomen, upper arms and thighs. This is more pronounced with faster or larger weight reductions, and it is not specific to semaglutide: it happens with any significant weight change. The Wegovy clinical trial programme, which involved thousands of adults over 68 weeks, did not identify skin laxity as an adverse event, but it is a real and common patient concern.

Those experiencing significant dryness or texture changes often benefit from a plain, fragrance-free moisturiser applied to damp skin, and our page on managing semaglutide dry skin goes into more detail on practical approaches. Whether more targeted cosmetic or dermatological input helps depends on the degree of laxity, and that conversation belongs with a GP or dermatologist, not with a weight-loss prescriber.

Step 3 (Itching and rash: when to watch, when to act

Itching) with or without a visible rash, is noted in the semaglutide side-effect data. It can reflect dry skin (addressed above), a mild local reaction, or occasionally a broader immune response to the medicine. Mild, localised itching that comes and goes is generally low priority if it does not interfere with daily life. A question patients ask our prescribers regularly is whether widespread itching, or itching alongside yellowing skin or eyes, could signal something more serious: it can, and in that combination it warrants same-day medical assessment, as it may indicate liver involvement.

Anyone experiencing jaundice alongside itching should contact their GP or call 111 promptly. Itching related to an allergic reaction is usually accompanied by urticaria (hives), facial swelling or breathing changes, that is an emergency. More detail on the full range of skin-related effects associated with Wegovy is available if you want to read further.

If skin changes are a concern but you are not yet on treatment, it is worth knowing that semaglutide is a prescription-only medicine and every course begins with a clinical assessment. Skin history (including allergies or existing conditions like eczema or psoriasis) forms part of that conversation. A prescriber can flag whether a skin condition means treatment needs to be approached with extra care.

Step 4, Putting it together: skin changes and your overall progress

Most skin changes on semaglutide are manageable and temporary, particularly those tied to the early weeks of treatment or to dose increases. Injection-site reactions usually diminish once the body adjusts. Dryness often responds to hydration and a good moisturiser. Laxity is a slower, longer-term concern that depends heavily on the degree of weight lost, age and individual skin elasticity, and there is no prescription answer to it.

If you are already on Wegovy and have concerns about your skin that have not settled, the right first step is to raise them with whoever is managing your treatment. If that is proving difficult, our aftercare team is available seven days a week. If you are still exploring treatment options and want to understand what to expect from Wegovy more broadly, including how it works and who it is licensed for, that information is a good starting point.

Treatment is a clinical decision made with a prescriber who knows your history. The team at nume includes GPhC-registered Independent Prescribers who review every consultation personally. If you are weighing up your options, a free consultation is the place to start that conversation.